Cargando…
APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts
BACKGROUND: With the onset of prevention trials for individuals at high risk for Alzheimer disease, there is increasing need for accurate risk prediction to inform study design and enrollment, but available risk estimates are limited. We developed risk estimates for the incidence of mild cognitive i...
Autores principales: | Qian, Jing, Wolters, Frank J., Beiser, Alexa, Haan, Mary, Ikram, M. Arfan, Karlawish, Jason, Langbaum, Jessica B., Neuhaus, John M., Reiman, Eric M., Roberts, J. Scott, Seshadri, Sudha, Tariot, Pierre N., Woods, Beth McCarty, Betensky, Rebecca A., Blacker, Deborah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360223/ https://www.ncbi.nlm.nih.gov/pubmed/28323826 http://dx.doi.org/10.1371/journal.pmed.1002254 |
Ejemplares similares
-
Alzheimer's Prevention Initiative Generation Program: Development of an APOE genetic counseling and disclosure process in the context of clinical trials
por: Langlois, Carolyn M., et al.
Publicado: (2019) -
Life expectancy with and without dementia in persons with mild cognitive impairment in the community
por: Mooldijk, Sanne S., et al.
Publicado: (2021) -
SURVIVAL ADVANTAGE OF APOE2
por: Seshadri, Sudha
Publicado: (2019) -
Brain imaging biomarkers for the Alzheimer’s Prevention Initiative
por: Chen, Kewei, et al.
Publicado: (2012) -
Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer’s disease: Pooled analysis from 5 cohorts
por: Weinstein, Galit, et al.
Publicado: (2019)